INSP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
INSP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Inspire Medical Systems's Marketable Securities for the quarter that ended in Mar. 2024 was $265.9 Mil.
Inspire Medical Systems's annual Marketable Securities increased from Dec. 2021 ($0.0 Mil) to Dec. 2022 ($9.8 Mil) and increased from Dec. 2022 ($9.8 Mil) to Dec. 2023 ($274.8 Mil).
The historical data trend for Inspire Medical Systems's Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspire Medical Systems Annual Data | |||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
Marketable Securities | Get a 7-Day Free Trial | 126.61 | 43.84 | - | 9.82 | 274.84 |
Inspire Medical Systems Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Marketable Securities | Get a 7-Day Free Trial | 9.93 | - | 134.32 | 274.84 | 265.95 |
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.
Inspire Medical Systems (NYSE:INSP) Marketable Securities Explanation
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
Thank you for viewing the detailed overview of Inspire Medical Systems's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.
Timothy P. Herbert | director, 10 percent owner, officer: CEO and President | C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369 |
Jerry C Griffin | director | 887L INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Carlton Weatherby | officer: Chief Strategy Officer | C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369 |
Steven Jandrich | officer: Chief Comp Off & VP, Human Res | C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369 |
Philip Ebeling | officer: Chief Operating Officer | INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416 |
John Rondoni | officer: Chief Technology Officer | C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369 |
Richard Buchholz | officer: Chief Financial Officer | C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369 |
Randy Ban | officer: Senior VP. & Sales & Marketing | C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369 |
Marilyn C Nelson | director | C/O EXXON MOBIL CORP, 5959 LAS COLINAS BLVD., IRVING TX 75039-2298 |
Cynthia Burks | director | C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369 |
Charisse Y Sparks | director | C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369 |
Georgia Melenikiotou | director | C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BOULEVARD, SUITE 1600, GOLDEN VALLEY MN 55416 |
Bryan K Phillips | officer: See Remarks | 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344 |
Shelley G. Broader | director | 880 CARILLON PARKWAY, ST. PETERSBURG FL 33702 |
Casey M Tansey | director, 10 percent owner | 2735 SAND HILL ROAD, MENLO PARK CA 94025 |
From GuruFocus
By PRNewswire • 01-22-2024
By PRNewswire • 01-09-2024
By PRNewswire • 01-14-2024
By PRNewswire • 01-16-2024
By PRNewswire • 01-12-2024
By PRNewswire • 01-05-2024
By Business Wire • 01-03-2024
By Business Wire • 01-02-2024
By PRNewswire • 01-18-2024
By Business Wire • 12-28-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.